A new Mycobacterium leprae dihydropteroate synthase variant (V39I) from Papua, Indonesia
- Yustinus Maladan
- Hana Krismawati
- Hotma Martogi Lorensi Hutapea
- Antonius Oktavian
- Ratu Fatimah
- Widodo
DOIAbstract
Indonesia had the third highest number of new leprosy cases worldwide in 2017. This disease is still prevalent in Papua province, where the number of new cases in 2014 (3.0 cases per 10,000 people) is considered highly endemic and is well above the World Health Organization's (WHO) cutoff of <1 new case per 10,000 people. Since 1995, the WHO has supplied Papua province with a multi-drug therapy (MDT) in which multibacillary (MB) patients are treated with rifampicin, clofazimine, and dapsone and paucibacillary (PB) patients are treated with rifampicin and dapsone. Recent published data on global drug resistance reported cases of dapsone resistance in relapsed and newly diagnosed cases in Indonesia during this period. The detection of specifi...
Add to ORKG